PT  - JOURNAL ARTICLE
ED  - ,
TI  - ▾ Halofantrine – an alternative treatment for malaria
AID  - 10.1136/dtb.31.15.59
DP  - 1993 Jul 19
TA  - Drug and Therapeutics Bulletin
PG  - 59--60
VI  - 31
IP  - 15
4099  - http://dtb.bmj.com/content/31/15/59.short
4100  - http://dtb.bmj.com/content/31/15/59.full
SO  - Drug Ther Bull1993 Jul 19; 31
AB  - Halofantrine (Halfan – SKB) is a new phenanthrene antimalarial introduced last year for the oral treatment of patients with falciparum and vivax malaria. The data sheet states that it is especially useful for the treatment of patients “likely to be infected with chloroquine or multi-drug-resistant strains of malaria”. We have previously discussed drug treatments for choroquine-resistant malaria.1 Where does halofantrine fit in?